Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Pathological Analysis of Nivolumab Combo in Resectable NSCLC Nov 20, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Osimertinib Shows Favorable Outcomes In Final OS Analysis Of NSCLC Patients Nov 17, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Amivantamab Proves Effective In Advanced NSCLC Patients With METex 14 Mutations Nov 16, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Tepotinib + Osimertinib in EGFR-Mutant NSCLC With MET Amplification After 1L Osimertinib Nov 15, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),SCLC (Small Cell Lung Cancer) Multisite SBRT + Ipilimumab + Nivolumab Is Well-Tolerated In First Line Metastatic NSCLC Nov 14, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Dendritic Cell Immunotherapy Vs. Best Supportive Care As A Maintenance Treatment In UPM Patients Nov 14, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Lazertinib Is Effecive In NSCLC Patients With Uncommon EGFR Mutations Nov 14, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Dato-DXd Vs. Docetaxel In Previously Treated Adv/Met NSCLC Nov 09, 2023
